Head and Neck CancerGenetics
What this study is
Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.
Study details
- Sponsor
- Stanford University
- Conditions
- Head and Neck Cancer
- Enrolling
- 500 people
- Starts
- 2002-04-02
- Est. completion
- 2030-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- All patients undergoing surgery at Stanford University for head and neck cancer.
You can't join if
- Non-Stanford patients.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Study locations (1)
1 openStanford University School of Medicine
Stanford, California, United States
- Nikita Bedi · Contact650-723-5957nbedi@stanford.edu
- Cancer Clinical Trials Office · Contact(650) 498-7061
- Quynh-Thu Le · Sub-investigator
- Willard E Fee Jr · Sub-investigator
- Zijie Sun · Sub-investigator
- Jan Matthijs van de Rijn · Sub-investigator
- Dr Michael Kaplan · Sub-investigator
- John B Sunwoo · Principal investigator
Recruiting
Study team
Sponsor
Stanford University
Study ID IRB-11402
Principal investigator
John B Sunwoo
Stanford University
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.